Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Courtney Miller-Chism

General Oncology · BCM

View

Dr. Michele Evans

General Oncology · NIH

View

Dr. Hannah Knochelmann

General Oncology

View

Dr. Don Dizon

General Oncology · Tufts Medicine

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    PFDr. Paula Fraenkel

    Dr. Paula Fraenkel

    Hematology & Oncology · General Oncology
    AstraZeneca
    paulaf

    Research

    Durvalumab Plus Chemotherapy in Patients With-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARD

    2026

    Via JTO Clinical and Research Reports

    Research

    Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia

    2025

    Via Blood Advances

    Research

    IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

    2025

    Via Cancer Research Communications

    Research

    Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

    2025

    Via Clinical Cancer Research

    Research

    Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report

    2025

    Via Journal of Thoracic Oncology

    Research

    Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment

    2021

    Via Oncoimmunology

    Research

    Genetic screens reveal CCDC115 as a modulator of erythroid iron and heme trafficking

    2020

    Via American Journal of Hematology

    Research

    Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

    2020

    Via European Journal of Cancer

    Research

    Molecular Genetic Abnormalities in the Genome of Patients with Ph-Negative Myeloproliferative Neoplasia Affected by Ionizing Radiation as a Result of the Chornobyl Nuclear Accident

    2020

    Via Problemy Radiatsiinoi Medytsyny ta Radiobiolohii

    Research

    Copy Number Alterations and Copy-Neutral Loss of Heterozygosity in Ukrainian Patients with Primary Myelofibrosis

    2019

    Via Experimental Oncology

    Research

    Copy number alterations and copy-neutral loss of heterozygosity in Ukrainian patients with primary myelofibrosis

    2019

    Via Experimental Oncology

    Research

    Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident

    2018

    Via American Journal of Hematology

    Research

    Anemia of Inflammation: A Review

    2017

    Via The Medical Clinics of North America

    Research

    Nicotinamide N-methyltransferase expression decreases in iron overload, exacerbating toxicity in mouse hepatocytes

    2017

    Via Hepatology Communications

    Research

    Dietary supplementation with ipriflavone decreases hepatic iron stores in wild type mice

    2016

    Via Blood Cells, Molecules & Diseases